Skip to main content
MedinCell S.A. logo

MedinCell S.A. — Investor Relations & Filings

Ticker · MEDCL ISIN · FR0004065605 LEI · 969500R79U6PXCL2FF46 PA Manufacturing
Open in API
Filings indexed 522 across all filing types
Latest filing 2021-08-04 AGM Information
Country FR France
Listing PA MEDCL

About MedinCell S.A.

https://www.medincell.com/en/

MedinCell S.A. is a pharmaceutical company at the commercial stage that specializes in the development of long-acting injectable (LAI) therapies. The company's core is its proprietary BEPO® technology platform, which enables the controlled and sustained release of active pharmaceutical ingredients over periods ranging from days to months after a single injection. This technology forms a fully biodegradable depot in situ, designed to improve treatment efficiency, enhance patient compliance, and increase the global accessibility of medicines. MedinCell develops a portfolio of LAI products across various therapeutic areas, including psychiatry, advancing its pipeline through both internal research and strategic partnerships with other pharmaceutical organizations.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
AGM Information Classification · 98% confidence The document is titled "Modalités de participation à l'Assemblée Générale Mixte des actionnaires" (Participation modalities for the Combined General Meeting of Shareholders). It explicitly discusses the date, time, and procedures (voting via Votaccess, video conference, questions) for the upcoming Annual General Meeting (AGM) scheduled for September 9, 2021. This content directly relates to the logistics and information provided for the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a proxy statement (PSI) or a declaration of voting results (DVA), but rather the announcement detailing how shareholders can participate in the meeting.
2021-08-04 French
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document explicitly discusses the 'Participation terms in the MedinCell Combined General Meeting' and details the procedures for holding the meeting ('Annual General Meeting will be held in closed session on September 9, 2021'), remote voting deadlines, and a related video conference presentation. This content directly relates to the organization, procedures, and materials surrounding the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2021-08-04 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 98% confidence The document is a press release dated July 28, 2021, announcing that MedinCell has filed its Universal Registration Document (URD) 2020/2021 with the AMF (Autorité des Marchés Financiers). The text explicitly states that the URD *includes* the annual financial report, management report, CSR report, governance report, and draft resolutions for the upcoming AGM. Since the document itself is an announcement about the publication of these reports, and not the full Annual Report (10-K) or the AGM materials themselves, it fits the definition of a Report Publication Announcement (RPA). The document length (2619 chars) is short, supporting the 'announcement' classification over the full report classification.
2021-07-28 French
Inside Information / Other news releases
Report Publication Announcement Classification · 98% confidence The document is a press release dated July 28, 2021, announcing the filing of the '2020/2021 Universal Registration Document (URD)' with the French market authority (AMF). The document explicitly states that the URD includes the annual financial report, management report, CSR report, and governance report, and resolutions for the upcoming Shareholders' Meeting. Since the text is an announcement about the publication/filing of a comprehensive annual document (URD, which contains the Annual Financial Report), and the document length is relatively short (2513 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the full Annual Report (10-K) or the AGM materials (AGM-R) itself. It is announcing the availability of the report.
2021-07-28 English
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a short press release dated July 26, 2021, announcing that the brokerage firm ODDO-BHF has initiated coverage of MedinCell's stock. It provides a brief summary of the coverage report's title and mentions existing coverage by other firms. This type of announcement, which publicizes external analysis or research coverage rather than being a formal regulatory filing (like 10-K, ER, or IR) or a specific corporate action report (like DIV, CAP, or DIRS), fits best under the general category for miscellaneous regulatory or corporate announcements that don't have a more specific code. Given the options, 'Regulatory Filings' (RNS) serves as the most appropriate fallback for general corporate news releases that don't fit the defined categories like Earnings Release (ER) or Management Discussion (MDA). It is not a report itself, but an announcement about external analysis.
2021-07-26 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is a press release from MedinCell dated July 26, 2021, announcing that the stock has initiated coverage by the brokerage firm ODDO-BHF. It mentions that this coverage adds to existing tracking by Bryan Garnier and Kepler Cheuvreux. This type of announcement, which concerns analyst coverage and investor relations visibility, does not fit neatly into the specific categories like 10-K, ER, or DIV. It is a general corporate announcement related to investor perception and market tracking. Since it is not a formal regulatory filing (like DIRS or MRQ) and doesn't fit the other specific financial/corporate event categories, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general announcement to the market regarding investor relations activity.
2021-07-26 French

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.